ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2026 Earnings Call Transcript March 12, 2026 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.06086 EPS, expectations ...

Lens AI, powered by the proprietary HIFT system, advanced functional adjacency capabilities and identified a single conserved functional feature across 2,000+ influenza sequences. Dengue Pipeline -- ...

Thank you for joining us today for MindWalk Holdings Corp.'s Third Quarter Fiscal Year 2026 Earnings Call. MindWalk trades on the NASDAQ under the ticker HYFT. Today's call will be led by our Chief ...

Strategic Trends in Garment Stabilization The garment interlining sector is currently undergoing a structural transformation driven by innovations in material science and significant shifts in global ...

With demand for high-quality protein ingredients accelerating, manufacturers are under pressure to boost yield, purity and sustainability. Filtration, separation, and purification technologies ...

Abstract: Characterizing brain dynamic functional connectivity (dFC) patterns from functional Magnetic Resonance Imaging (fMRI) data is of paramount importance in imaging neuroscience and medicine.

Polyvagal theory, introduced in 1994 by psychologist Stephen Porges, highlights the role of the autonomic nervous system in regulating our health and behavior. Our lived experience of engaging with ...

—The continued presence of locally advanced, operable breast cancer, particularly among patients with HR-positive/HER2-negative disease, highlights the need for ...

Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the stocks on Jim Cramer’s recent game plan. Cramer noted what could happen to the stock despite a “terrific number.” He remarked: After the close, ...

Introduction Dyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure.

MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an application of its proprietary HYFT® technology ...